Mota Ventures Corp. (CSE:MOTA FSE: 1WZ:GR OTC: PEMTF) (the 'Company' or 'Mota Ventures') is pleased to announce that it has entered into a binding agreement (the 'Transaction Agreement') dated January 9, 2020, with VIDA BCN LABS SL (Spain) and Sativida OU (Estonia) (collectively, 'Sativida') under which the Company has been granted the right to acquire Sativida (the 'Transaction').

Sativida is an arms'-length producer and online retailer of cannabidiol ('CBD') and branded CBD products in various jurisdictions in Europe, including Spain, Portugal, Austria, Germany, France and the United Kingdom.

Sativida currently develops and retails a vast range of organic CBD oils and cosmetics across Europe and is in the process of expanding its distribution network internationally to include the United States. Sativida has become the number one search-ranked online retailer of CBD products in Spain and Mexico, and intends to continue its expansion into other countries in Europe and Latin America. Joel Shacker, CEO of the Company, commented, 'We are excited to be at the forefront of the expansion of the CBD market in Europe and internationally. Currently, product availability and consumer awareness is in its infancy and the market is fragmented. The acquisition of an established brand such as Sativida is a great opportunity to both enter and expand in Europe. Using our newly formed and integrated infrastructure, we plan to rapidly capture market share and consolidate consumer bases across Europe. Sativida is the cornerstone for our entry into that market.' In accordance with the Transaction Agreement, the acquisition of Sativida will proceed in stages, at the discretion of the Company, as certain corporate and intellectual property registrations are completed. Initially, the Company will establish a wholly-owned Spanish subsidiary ('Spanish Subco'), and Sativida will coordinate the registration of various intellectual property and trade names associated with its business operations. Spanish Subco will then acquire the intellectual property and trade names of Sativida, and will license both back to Sativida in exchange for a royalty associated with the gross revenues generated by Sativida. The Company also holds the right to acquire, through Spanish Subco, all of the outstanding share capital of Sativida at any time. Following completion of the initial licensing arrangement, the Company expects to provide Sativida with contacts to distributors and partners across Europe and North America to allow for expansion of the Sativida brand, as well as logistical and financial support. Consideration for the Transaction will be made up of an initial component of EUR2,000,001 (the 'Initial Consideration') and an earn-out component made up of three milestone payments based upon the revenue of Sativida (each, a 'Milestone Payment').

About Mota Ventures Corp.

Mota Ventures is seeking to become a vertically integrated global CBD brand. Its plan is to cultivate and extract CBD into high-quality value added products from its Latin American operations and distribute it both domestically and internationally. Its existing operations in Colombia consist of a 2.5-hectare site that has optimal year round growing conditions and access to all necessary infrastructure. Mota Ventures is also seeking to acquire revenue producing CBD brands and operations in both Europe and North America, with the goal of establishing an international distribution network for CBD products. Low cost production, coupled with international, direct to customer, sales channels will provide the foundation for the success of Mota Ventures.

Contact:

Tel: +1.604.423.4733

All statements in this press release, other than statements of historical fact, are 'forward-looking information' with respect to the Company within the meaning of applicable securities laws including with respect to the completion of the acquisition of Sativida, the expansion of Sativida's business and its cultivation operations in Colombia. When or if used in this news release, the words 'anticipate', 'believe', 'estimate', 'expect', 'target, 'plan', 'forecast', 'may', 'schedule' and similar words or expressions identify forward-looking statements or information. The Company provides forward-looking statements for the purpose of conveying information about current expectations and plans relating to the future, and readers are cautioned that such statements may not be appropriate for other purposes. By its nature, this information is subject to inherent risks and uncertainties that may be general or specific and which give rise to the possibility that expectations, forecasts, predictions, projections or conclusions will not prove to be accurate, that assumptions may not be correct and that objectives, strategic goals and priorities will not be achieved. These risks and uncertainties include but are not limited those identified and reported in the Company's public filings under the Company's SEDAR profile at www.sedar.com. Although the Company has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking information, there may be other factors that cause actions, events or results not to be as anticipated, estimated or intended. Such factors include the result of further due diligence investigation of the business and operations of Sativida. There can be no assurance that such information will prove to be accurate as actual results and future events could differ materially from those anticipated in such statements. The Company disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise unless required by law.

(C) 2020 Electronic News Publishing, source ENP Newswire